BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30085159)

  • 1. Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn's Disease: A French Population-Based Study.
    Duricova D; Sarter H; Savoye G; Leroyer A; Pariente B; Armengol-Debeir L; Bouguen G; Ley D; Turck D; Templier C; Buche S; Peyrin-Biroulet L; Gower-Rousseau C; Fumery M;
    Inflamm Bowel Dis; 2019 Jan; 25(2):394-402. PubMed ID: 30085159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-intestinal Manifestations at Diagnosis in Paediatric- and Elderly-onset Ulcerative Colitis are Associated With a More Severe Disease Outcome: A Population-based Study.
    Duricova D; Leroyer A; Savoye G; Sarter H; Pariente B; Aoucheta D; Armengol-Debeir L; Ley D; Turck D; Peyrin-Biroulet L; Gower-Rousseau C; Fumery M;
    J Crohns Colitis; 2017 Oct; 11(11):1326-1334. PubMed ID: 28981648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based Study.
    Fumery M; Pariente B; Sarter H; Charpentier C; Armengol Debeir L; Dupas JL; Coevoet H; Peyrin-Biroulet L; dʼAgay L; Gower-Rousseau C; Savoye G;
    Inflamm Bowel Dis; 2016 Jul; 22(7):1698-707. PubMed ID: 27206018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking increases the risk of extraintestinal manifestations in Crohn's disease.
    Ott C; Takses A; Obermeier F; Schnoy E; Müller M
    World J Gastroenterol; 2014 Sep; 20(34):12269-76. PubMed ID: 25232261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
    Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
    Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment.
    Greuter T; Bertoldo F; Rechner R; Straumann A; Biedermann L; Zeitz J; Misselwitz B; Scharl M; Rogler G; Safroneeva E; Ali RAR; Braegger C; Heyland K; Mueller P; Nydegger A; Petit LM; Schibli S; Furlano RI; Spalinger J; Schäppi M; Zamora S; Froehlich F; Herzog D; Schoepfer AM; Vavricka SR;
    J Pediatr Gastroenterol Nutr; 2017 Aug; 65(2):200-206. PubMed ID: 27801751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study.
    Fumery M; Pariente B; Sarter H; Savoye G; Spyckerelle C; Djeddi D; Mouterde O; Bouguen G; Ley D; Peneau A; Dupas JL; Turck D; Gower-Rousseau C;
    Dig Liver Dis; 2019 Apr; 51(4):496-502. PubMed ID: 30611597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications.
    Herzog D; Fournier N; Buehr P; Rueger V; Koller R; Heyland K; Nydegger A; Spalinger J; Schibli S; Petit LM; Braegger CP;
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):598-607. PubMed ID: 29360691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
    Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
    Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.
    Tadbiri S; Peyrin-Biroulet L; Serrero M; Filippi J; Pariente B; Roblin X; Buisson A; Stefanescu C; Trang-Poisson C; Altwegg R; Marteau P; Vaysse T; Bourrier A; Nancey S; Laharie D; Allez M; Savoye G; Gilletta C; Gagniere C; Vuitton L; Viennot S; Aubourg A; Pelletier AL; Bouguen G; Abitbol V; Fumery M; Claudepierre P; Bouhnik Y; Amiot A;
    Aliment Pharmacol Ther; 2018 Feb; 47(4):485-493. PubMed ID: 29250803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
    Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL
    World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural History of Anal Ulcerations in Pediatric-Onset Crohn's Disease: Long-Term Follow-Up of a Population-Based Study.
    Mortreux P; Leroyer A; Dupont C; Ley D; Bertrand V; Spyckerelle C; Guillon N; Wils P; Gower-Rousseau C; Savoye G; Fumery M; Turck D; Siproudhis L; Sarter H
    Am J Gastroenterol; 2023 Sep; 118(9):1671-1678. PubMed ID: 37104674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extra-intestinal manifestations associated with Crohn's disease].
    Ayada I; van Wijk MP; de Boer NK; de Hoog J; Kneepkens CMF; de Meij TJG
    Ned Tijdschr Geneeskd; 2024 May; 168():. PubMed ID: 38780190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.
    Louis EJ; Reinisch W; Schwartz DA; Löfberg R; Robinson AM; Berg S; Wang AW; Maa JF; Huang B; Pappalardo B
    Adv Ther; 2018 Apr; 35(4):563-576. PubMed ID: 29516410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of new-onset Crohn's disease in children and adolescents in dependency of age, initial location, initial severity level and therapy over the period 2000-2014 based on the Saxon Pediatric IBD-Registry in Germany.
    Dong F; Kern I; Weidner J; Kügler K; Rothe U; Amin M; Laaß MW; Flemming G; Winkler U; Richter T; Kugler J; Manuwald U
    PLoS One; 2023; 18(6):e0287860. PubMed ID: 37384664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraintestinal Manifestations Are Associated With Disease Severity in Pediatric Onset Inflammatory Bowel Disease.
    Jansson S; Malham M; Paerregaard A; Jakobsen C; Wewer V
    J Pediatr Gastroenterol Nutr; 2020 Jul; 71(1):40-45. PubMed ID: 32187141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
    Saad AM; Czul F; Sakuraba A; Rubin DT; Cohen RD
    Inflamm Bowel Dis; 2016 May; 22(5):1027-31. PubMed ID: 26919459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.